Row
U
UTHRAI Stock Diagnostic Report
United Therapeutics chairperson & CEO Martine Rothblatt sells $5.2m in stock
The sale of $5.2 million in company stock by United Therapeutics' Chairman and CEO could negatively impact investor sentiment.
View Source Article ↗
AI CATALYST SCORE40 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
UTHR Analysis History (Last 30 Days)